Scheriproct
Scheriproct is a medicine authorised by Swissmedic under authorisation number 24137. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 August 1958 and the authorisation is valid without a time limit. ATC code C05AA04 places the medicine in the group Vasoprotectives.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Scheriproct, Rektalsalbe | B | 20 August 1958 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | g | C05AA04 | 02.09.2. | B |
| 2 | 30 | g | C05AA04 | 02.09.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Scheriproct authorised in Switzerland?
Yes. Scheriproct is authorised by Swissmedic under authorisation number 24137, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Scheriproct have?
Scheriproct is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Scheriproct?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.